Related Experiment Video
Updated: Sep 21, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
William Mm Levack1, Betty Poot2,3, Mark Weatherall1
1University of Otago, Rehabilitation Teaching and Research Unit, Department of Medicine, Mein St, Newtown, PO Box 7343, Wellington, New Zealand, 6242.
Sexual dysfunction is common in chronic obstructive pulmonary disease (COPD). Limited evidence suggests testosterone therapy may improve erectile function in men with COPD, but more research is needed.
Area of Science:
- Pulmonary Medicine
- Sexual Health
- Clinical Trials
Background:
- Chronic obstructive pulmonary disease (COPD) is associated with a higher risk of sexual dysfunction compared to age-matched individuals.
- Sexual health issues in COPD can stem from hormonal, physiological, psychological factors, or relationship changes due to the chronic condition.
Purpose of the Study:
- To evaluate the effectiveness of interventions aimed at improving sexual dysfunction in individuals with COPD.
Main Methods:
- Searched multiple databases (e.g., Cochrane, MEDLINE, EMBASE) and trials registers up to July 2015.
- Included randomized controlled trials (RCTs), cluster RCTs, and quasi-RCTs assessing pharmacological, mechanical, psychological, or educational interventions.
- Two authors independently reviewed studies, extracted data, and assessed risk of bias.
Main Results:
- Included two studies with 48 male participants (moderate to very severe COPD).
- Low-quality evidence suggests testosterone therapy may improve erectile function, but not overall sexual satisfaction.
- Insufficient data exists on adverse events of testosterone therapy or the effects of oxygen therapy on erectile dysfunction.
Conclusions:
- Current clinical trial evidence is insufficient to guide interventions for sexual dysfunction in COPD patients.
- Clinicians currently rely on studies of non-COPD populations and expert opinion.
- Further clinical trials are necessary to establish effective interventions for improving sexual function and satisfaction in people with COPD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

